Try our Advanced Search for more refined results
RiconPharma LLC
-
Order | Filed: August 21, 2023 | Entered: August 21, 2023 SUPERNUS PHARMACEUTICALS, INC. v. RICONPHARMA LLC et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Stipulation and Order Order of Dismissal
STIPULATION and ORDER of Dismissal without Prejudice. Signed by Judge Michael E. Farbiarz on 8/21/2023. (dam)
-
Misc | Filed: August 18, 2023 | Entered: August 18, 2023 SUPERNUS PHARMACEUTICALS, INC. v. RICONPHARMA LLC et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Letter
Letter from Supernus to the Hon. Michael E. Farbiarz, U.S.D.J.. (BATON, WILLIAM)
-
Order | Filed: August 17, 2023 | Entered: August 17, 2023 SUPERNUS PHARMACEUTICALS, INC. v. RICONPHARMA LLC et al
Patent - Abbreviated New Drug Application(ANDA) | New Jersey
Order
TEXT ORDER: The Telephone Status Conference on 8/24/2023 is adjourned to 10/13/2023 at 2:30 p.m. The parties will dial 1-888-684-8852 and access code 1456817# to join the conference. So Ordered by Magistrate Judge Michael A. Hammer on 8/17/2023. (jqb, )
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login